ISIN | CH0226274212 |
---|---|
Valor Number | 22627421 |
Bloomberg Global ID | UBANF US |
Fund Name | UBS ETF (CH) - UBS MSCI Switzerland hUSD ETF USD dis |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The UBS ETF (CH) – MSCI Switzerland 100% hedged to USD is an exchange traded fund incorporated in Switzerland. The objective of the Fund is to deliver the net total return performance of the MSCI Switzerland 100% hedged to USD and allow intraday trading. |
Peculiarities |
Current Price * | 28.65 USD | 12.09.2025 |
---|---|---|
Previous Price * | 28.85 USD | 11.09.2025 |
52 Week High * | 29.04 USD | 20.03.2025 |
52 Week Low * | 24.25 USD | 09.04.2025 |
NAV * | 28.65 USD | 12.09.2025 |
Issue Price * | 28.65 USD | 12.09.2025 |
Redemption Price * | 28.65 USD | 12.09.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 461,095,489 | |
Unit/Share Assets *** | 461,095,489 | |
Trading Information SIX |
YTD Performance | +11.97% |
31.12.2024 - 12.09.2025
31.12.2024 12.09.2025 |
---|---|---|
YTD Performance (in CHF) | -1.73% |
31.12.2024 - 12.09.2025
31.12.2024 12.09.2025 |
1 month | +3.15% |
12.08.2025 - 12.09.2025
12.08.2025 12.09.2025 |
3 months | +0.68% |
12.06.2025 - 12.09.2025
12.06.2025 12.09.2025 |
6 months | +0.42% |
12.03.2025 - 12.09.2025
12.03.2025 12.09.2025 |
1 year | +10.35% |
12.09.2024 - 12.09.2025
12.09.2024 12.09.2025 |
2 years | +27.50% |
12.09.2023 - 12.09.2025
12.09.2023 12.09.2025 |
3 years | +36.00% |
12.09.2022 - 12.09.2025
12.09.2022 12.09.2025 |
5 years | +52.23% |
14.09.2020 - 12.09.2025
14.09.2020 12.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 12.09.2025 |
Novartis AG Registered Shares | 13.10% | |
---|---|---|
Nestle SA | 12.97% | |
Roche Holding AG | 12.79% | |
UBS Group AG Registered Shares | 6.94% | |
ABB Ltd | 6.07% | |
Zurich Insurance Group AG | 5.74% | |
Compagnie Financiere Richemont SA Class A | 5.46% | |
Swiss Re AG | 2.86% | |
Lonza Group Ltd | 2.68% | |
Holcim Ltd | 2.35% | |
Last data update | 10.09.2025 |
TER | 0.25% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.23% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |